Integra LifeSciences Holdings Corporation (IART) on Thursday reported a loss of $1.70 million, or $0.02 per share for the fourth quarter, compared with a profit of $19.44 million, or $0.25 per share, in the same quarter last year.
Excluding one-time items, the company posted earnings of $63.7 million, or $0.83 per share.
Operating income fell to $23.04 million from $35.63 million a year earlier.
Total revenue edged down 1.7% to $434.93 million from $442.65 million in the prior-year quarter.
Integra LifeSciences expects full-year 2026 revenue of $1.662 billion to $1.702 billion, representing a growth of 1.6% to 4.1%. Adjusted earnings per share are projected at $2.30 to $2.40.
For the first quarter, the company forecasts revenue of $375 million to $390 million, implying a decline of 2% to growth of 1.9%. Adjusted earnings per share are expected in the range of $0.37 to $0.45.
Integra LifeSciences shares closed at $11.59 on Wednesday, up 0.52%.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.